Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Investors overview.gif
Investor Relations Contact:
ir@anacor.com
Phone: 650-543-7575

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Anacor Pharmaceuticals, Inc.'s financial performance into perspective.

View all »Recent Releases

Nov 7, 2014
Anacor Pharmaceuticals to Present at the 2014 Credit Suisse Healthcare Conference

Nov 6, 2014
Anacor Pharmaceuticals Reports Third Quarter 2014 Financial Results

View all »Events & Presentations

Nov 13, 2014 at 9:00 AM MT
2014 Credit Suisse Healthcare Conference

Nov 6, 2014 at 5:00 PM ET
Anacor Third Quarter 2014 Financial Results Conference Call

Sep 9, 2014 at 3:30 PM ET
Morgan Stanley Global Healthcare Conference

Receive Email Alerts

Sign up to receive e-mail alerts whenever Anacor posts new information to the site.



(ANAC): NASDAQ
Price: 32.23 Change: +0.15
High: 32.50 %Change: 0.468%
Low: 31.40 Volume: 549,900